SSgA Funds Management, Inc. recently announced the acquisition of new stake in The Travelers Companies Inc. (NYSE:TRV). The institutional investor has increased its shareholding in the Financial company by 1.00% to 16.68 million shares with purchase of 0.17 million shares. This fresh investment now brings its stake to 7.19% valued currently at $3.09 billion. In addition, BlackRock Fund Advisors raised its holdings by 1.52 million to 12.64 million shares. And T. Rowe Price Associates, Inc. has lifted its position by 11.87% or 0.83 million shares – to 7.82 million shares.
With over 2.61 million The Travelers Companies Inc. (TRV) shares trading Monday and a closing price of $172.22 on the day, the dollar volume was approximately $449.97 million. The shares have shown a positive half year performance of 4.92% and its price on 03/13/23 lost nearly -1.97%. Currently, there are 233.10M common shares owned by the public and among those 230.20M shares have been available to trade.
Do You Know The Best Place To Find Gains In Volatile Markets?
In today's chaotic marketplace, the biggest gains will come from some currently-small companies that pass by older, larger businesses still stuck in a pre-pandemic world. The trick is figuring out which small caps will be tomorrow's winners. That's why StockWire News has put together a special Wealth Building Report, highlighting 3 small cap stocks set to soar in 2023.
Click here for full details and to join for free.
An analysis of what Wall Street brokers have to say about the expected price targets for this stock gives us this picture: 24 analysts who have offered their price forecasts for TRV have a consensus price objective of $198.50. The analysts have set the share’s price value over the next 12 months at a high of $230.00 and a low of $175.00. The average price target is 13.81% above its recent price level and an upside to the estimated low will see the stock gain 1.59% over that period. But an upside of 25.12% will see the stock hit the forecast high price target while median target price for the stock is $196.00.
Insiders at the company have transacted a total of 124 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 62 of these insider trades were purchases, accounting for 535,576 shares. Insider sales of the common stock occurred on 62 occasions, with total insider shares sold totaling 462,474 shares.
The top 3 mutual fund holders in The Travelers Companies Inc. are Vanguard Total Stock Market Index, SPDR Dow Jones Industrial Average, and Vanguard 500 Index Fund. Vanguard Total Stock Market Index owns 7.18 million shares of the company’s stock, all valued at over $1.33 billion. The company bought an additional 57063.0 shares recently to bring their total holdings to about 3.09% of the shares outstanding. SPDR Dow Jones Industrial Average bought 32940.0 shares to see its total holdings expand to 5.69 million shares valued at over $1.05 billion and representing 2.45% of the shares outstanding. Vanguard 500 Index Fund bought 12844.0 shares to bring its total holdings to over 5.43 million shares at a value of $1.01 billion. Vanguard 500 Index Fund now owns shares totaling to 2.34% of the shares outstanding.
Shares of The Travelers Companies Inc. (NYSE: TRV) opened at $173.25, down -$2.43 from a prior closing price of $175.68. However, the script later moved the day high at 176.65, down -1.97%. The company’s stock has a 5-day price change of -6.07% and -8.26% over the past three months. TRV shares are trading -8.14% year to date (YTD), with the 12-month market performance up to 0.19% higher. It has a 12-month low price of $149.65 and touched a high of $194.51 over the same period. TRV has an average intraday trading volume of 1.33 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -6.07%, -7.52%, and -1.33% respectively.
Institutional ownership of The Travelers Companies Inc. (NYSE: TRV) shares accounts for 85.10% of the company’s 233.10M shares outstanding. Mutual fund holders own 31.78%, while other institutional holders and individual stakeholders account for 52.78% and 1.36% respectively.
It has a market capitalization of $39.57B and a beta (3y monthly) value of 0.64. The stock’s trailing 12-month PE ratio is 14.65, while the earnings-per-share (ttm) stands at $11.76. The company has a PEG of 1.66 and the debt-to-equity ratio at 0.34. Price movements for the stock have been influenced by the stock’s volatility, which stands at 2.62% over the week and 1.74% over the month.
Analysts forecast that The Travelers Companies Inc. (TRV) will achieve an EPS of $3.68 for the current quarter, $2.6 for the next quarter and $16.76 for 2024. The lowest estimate earnings-per-share for the quarter is $3 while analysts give the company a high EPS estimate of $4.17. Comparatively, EPS for the current quarter was $4.22 a year ago. Earnings per share for the fiscal year are expected to decrease by -18.80%, and 16.89% over the next financial year. EPS should grow at an annualized rate of 8.83% over the next five years, compared to 8.60% over the past 5-year period.
If you are looking to buy this stock, then you may note that the average analyst recommendation by 24 brokerage firm advisors rate The Travelers Companies Inc. (TRV) as a “Moderate Buy” at a consensus score of 2.70. Specifically, 6 Wall Street analysts polled rate the stock as a buy, while 14 of the 24 advise that investors “hold,” and 3 rated it as a “Sell.”
Looking at the support for the TRV, a number of firms have released research notes about the stock. BMO Capital Markets stated their Outperform rating for the stock in a research note on January 20, 2023, with the firm’s price target at $212. Evercore ISI coverage for the The Travelers Companies Inc. (TRV) stock in a research note released on January 10, 2023 offered a Outperform rating with a price target of $220. Raymond James was of a view on July 25, 2022 that the stock is Strong Buy, while Wolfe Research gave the stock Peer Perform rating on June 23, 2022, issuing a price target of $185- $156. Goldman on their part issued Sell rating on June 03, 2022.
Leave a Reply